Assoc. Prof. Dr. Nah Hao | Cancer | Best Researcher Award

The first Hospital Affiliated to Xi’an Jiaotong University | China.

Author Profile

🎓EARLY ACADEMIC PURSUITS

Assoc. Prof. Dr. Na Hao began her medical journey at Nankai University School of Medicine, where she earned her Bachelor’s degree in Clinical Medicine (2008–2013), followed by a Master of Medicine in Surgery (2013–2015). Her early research delved into breast cancer biology, including clinical diagnostics and imaging techniques such as MRI. She went on to pursue a Ph.D. in Oncology (2015–2019) at the same institution, exploring tumor microenvironment, cancer stemness, and chemotherapy resistance, laying a strong foundation for her future breakthroughs.

💼PROFESSIONAL ENDEAVORS

Since June 2019, Dr. Na Hao has served as an Attending Surgeon and Associate Professor at The First Hospital Affiliated to Xi’an Jiaotong University. Combining clinical precision with scientific inquiry, she operates on the front lines of breast cancer treatment while leading pioneering cancer research. Her dual role as clinician and academic reflects a rare blend of medical excellence and intellectual leadership.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON CANCER

Dr. Hao’s research is highly translational, targeting some of the most pressing challenges in oncology, including:

Tumor angiogenesis and immunotherapy resistance, crucial for understanding tumor progression and treatment failure.
Endocrine and chemotherapy resistance in breast cancer, particularly HR+ and triple-negative breast cancer (TNBC).
Molecular signaling pathways, including PI3K mutations, ROS oxidative stress, and the role of AHNAK2 and PDE3A in cancer survival mechanisms.

Her research emphasizes the importance of precision medicine, with a focus on biomarkers such as CTCs (Circulating Tumor Cells) and ctDNA.

🌍IMPACT AND INFLUENCE

Public Health Education Ambassador for breast health awareness across 16 cities in China, promoting early detection and prevention.
International presenter at premier conferences such as the American Association for Cancer Research (AACR) and World Cancer Congress.
A textbook contributor to Parathyroidology, bridging the gap between clinical knowledge and student education.
Influential figure in the Chinese Society of Breast Prevention, contributing to national standards and outreach efforts.

🏆RESEARCH GRANTS AND FUNDING

Dr. Hao has successfully secured prestigious national and provincial grants as Principal Investigator, including:

2020–2023 – PDE3A-mediated endocrine resistance in HR+ breast cancer
National Natural Science Foundation of China (NSFC) – Grant No. 8-2003183
2022–2024 – AHNAK2’s role in chemotherapy resistance via ROS modulation in TNBC
Key R&D Program, Shanxi Province – Grant No. 2022SF-080

🦠LEGACY AND FUTURE CONTRIBUTIONS

Her patented invention of a low-temperature plasma surgical device (CN1041611584A) reflects her forward-thinking in surgical oncology.
Her current and future work focuses on overcoming resistance in breast cancer treatments, aiming to develop personalized therapies for improved patient outcomes.
As an educator, public speaker, and surgical expert, she is mentoring the next generation of oncologists and researchers.

🌟A VISIONARY IN INFECTIOUS DISEASES

Though primarily focused on cancer, Dr. Hao’s expertise in tumor microenvironments and immune resistance contributes to broader understandings in infectious diseases and immunopathology. Her cross-disciplinary insights are crucial for developing immunotherapy strategies that can be translated beyond oncology.

📑NOTABLE PUBLICATIONS

The role of magnetic resonance imaging in detection and surgical treatment of breast intraductal papillomas

Authors: Na Hao, Xiaoyan Yuan, Quansheng Wang, Junyong Zhu, Yiqiong Zheng, Yanjun Zhang, Mei Liu, Liuquan Cheng, Xiru Li

Publication Year: 2019

Journal: Translational Cancer Research

TIFA suppresses hepatocellular carcinoma progression via MALT1-dependent and -independent signaling pathways

Authors: Wenzhi Shen, Renle Du, Jun Li, Xiaohe Luo, Shaorong Zhao, Antao Chang, Wei Zhou, Ruifang Gao, Dehong Luo, Juan Wang, Na Hao, Yanhua Liu, Yanan Chen, Yunping Luo, Peiqing Sun, Shuang Yang, Na Luo, Rong Xiang

Publication Year: 2016

Journal: Signal Transduction and Targeted Therapy

ICAM3 mediates inflammatory signaling to promote cancer cell stemness

Authors: Wenzhi Shen, Junling Xie, Shaorong Zhao, Renle Du, Xiaohe Luo, Shan Jiang, Na Hao, Chong Chen, Chonglei Guo, Yanhua Liu, Yanan Chen, Peiqing Sun, Shuang Yang, Na Luo, Rong Xiang, Yunping Luo

Publication Year: 2018

Journal: Cancer Letters

Shanxi university | China.

Author Profile

Scopus

🎓EARLY ACADEMIC PURSUITS

Mrs. Qi Wang began her distinguished academic journey at Shanxi University, China, where she demonstrated exceptional aptitude in the biological sciences. Her passion for exploring the unseen microbial world laid a solid foundation for her specialization in Microbiology, particularly in pathogenic organisms and infectious disease mechanisms. Her early academic success was marked by her commitment to both theoretical excellence and hands-on laboratory skills.

💼PROFESSIONAL ENDEAVORS

Following her academic accomplishments, Mrs. Wang embarked on a progressive career in research and academia, contributing to university-led programs, government-sponsored research, and international collaborations. Her professional roles have included lead microbiologist, research supervisor, and lecturer, where she has mentored countless emerging scientists and shaped microbiology curricula.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON MICROBIOLOGY

Mrs. Wang’s research focuses on the molecular pathogenesis of infectious diseases, antibiotic resistance, and microbial genomics. Her cutting-edge studies have illuminated host-pathogen interactions, emerging microbial threats, and novel antimicrobial strategies. She is particularly known for her work on multidrug-resistant strains and novel diagnostic biomarkers, offering fresh insights into the global battle against infectious agents.

🌍IMPACT AND INFLUENCE

Mrs. Qi Wang’s work has had a far-reaching impact in the scientific community and beyond. Her findings have been pivotal in shaping public health strategies, influencing clinical microbiology protocols, and informing global antimicrobial policies. She is recognized for her interdisciplinary collaborations and her efforts to promote science-based healthcare decisions.

📚ACADEMIC CITATIONS

Her influential research is reflected in her impressive citation metrics across platforms like Google Scholar and ResearchGate. With numerous papers cited in top-tier microbiology and infectious disease journals, Mrs. Wang has become a trusted voice in the field, often referenced in systematic reviews, meta-analyses, and policy documents.

🏆RESEARCH GRANTS AND FUNDING

Mrs. Wang has secured multiple national and international grants, including funding from:

National Natural Science Foundation of China (NSFC)
Ministry of Education of the People’s Republic of China
Global Health Research Initiatives

Her projects have attracted competitive funding due to their innovation, clinical applicability, and potential for transformational outcomes in infectious disease management.

🦠LEGACY AND FUTURE CONTRIBUTIONS

Looking ahead, Mrs. Wang is committed to advancing precision microbiology, focusing on:

Personalized infectious disease treatment
Next-generation microbial diagnostics
Global surveillance systems for epidemic preparedness

She continues to mentor doctoral and postdoctoral researchers, ensuring a lasting legacy of scientific excellence and human impact.

🌟A VISIONARY IN INFECTIOUS DISEASES

Mrs. Qi Wang stands as a visionary leader in the field of infectious diseases, driven by an unwavering commitment to scientific discovery, clinical relevance, and global health equity. Her work exemplifies the synergy of innovation and compassion, embodying the values of a true academic pioneer.

📑NOTABLE PUBLICATIONS

Exopolysaccharide of Levilactobacillus brevis M-10 Improved Physiological and Biochemical Indicators and Gut Microbiota in DSS-Induced Colitis Mice

Authors: Qi Wang, Jiaqin Liu, Wenjun Qin, Jin Cai

Transcutaneous Auricular Vagus Nerve Stimulation in the Treatment of Disorders of Consciousness: Mechanisms and Applications

Authors: Qi Wang, Jiawei Peng, Ye Tian, Jin Cai, Wenjun Qin
Journal: Current Microbiology
Publication Year: 2025